| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.061 | 0.3 |